Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limitedverified

T14.SI

Price:

$3.17

Market Cap:

$26.41B

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceut...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-01-03

Stock Exchange

SES

Ticker

T14.SI

The Enterprise Value as of December 2025 (TTM) for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is 25.38B

According to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 25.38B. This represents a change of 4.32% compared to the average of 24.33B of the last 4 quarters.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Historical Enterprise Value (quarterly & annually)

How has T14.SI Enterprise Value performed in the past?

The mean historical Enterprise Value of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited over the last ten years is 15.38B. The current 25.38B Enterprise Value has changed 16.40% with respect to the historical average. Over the past ten years (40 quarters), T14.SI's Enterprise Value was at its highest in in the June 2023 quarter at 33.21B. The Enterprise Value was at its lowest in in the December 2018 quarter at 7.92B.

Quarterly (TTM)
Annual

Average

15.38B

Median

13.90B

Minimum

7.92B

Maximum

24.14B

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.17%

Maximum Annual Enterprise Value = 24.14B

Minimum Annual Increase = -26.59%

Minimum Annual Enterprise Value = 7.92B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202420.80B-13.82%
202324.14B22.23%
202219.75B-9.82%
202121.90B90.17%
202011.52B25.03%
20199.21B16.31%
20187.92B-26.59%
201710.79B-14.22%
201612.58B-17.43%
201515.23B32.10%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Average Enterprise Value

How has T14.SI Enterprise Value performed in the past?

The current Enterprise Value of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

21.56B

5-year avg

19.62B

10-year avg

15.38B

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Enterprise Value vs. Peers

How is T14.SI’s Enterprise Value compared to its peers?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s Enterprise Value is greater than Yanlord Land Group Limited (22.43B), greater than Haw Par Corporation Limited (2.77B), greater than China Aviation Oil (Singapore) Corporation Ltd (468.39M), greater than Valuetronics Holdings Limited (1.02B), greater than Q & M Dental Group (Singapore) Limited (572.30M),

Build a custom stock screener for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's Enterprise Value?

What is the highest Enterprise Value for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 3-year average Enterprise Value for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 5-year average Enterprise Value for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

How does the current Enterprise Value for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) compare to its historical average?